These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 21757356)

  • 21. Fragile histidine triad gene and skin cancer.
    Zanesi N; Croce CM
    Eur J Dermatol; 2001; 11(5):401-4. PubMed ID: 11525944
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Biochemical and immunochemical characterisation of human diadenosine triphosphatase provides evidence for its identification with the tumour suppressor Fhit protein.
    Asensio AC; Rodríguez-Ferrer CR; Oaknin S; Rotllán P
    Biochimie; 2006 May; 88(5):461-71. PubMed ID: 16359767
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Effects of ectogenous FHIT gene on reversing malignant phenotype of human lung adenocarcinoma cells A549].
    Wang Y; Zhuo Q; Qin Y; Yuan S; Sun Z; Wang Y; Chen X; Sun Z; Song Y; Yang Y
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2002 Jun; 19(3):225-9. PubMed ID: 12048684
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Restoration of fragile histidine triad (FHIT) expression inhibits cell growth and induces apoptosis in cutaneous T-cell lymphoma cell line.
    Song X; Tian Z; Wang S; Peng Z; Feng J
    Cancer Invest; 2010 Dec; 28(10):1019-23. PubMed ID: 20690795
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Enlightened protein: Fhit tumor suppressor protein structure and function and its role in the toxicity of protoporphyrin IX-mediated photodynamic reaction.
    Zawacka-Pankau J; Ferens B
    Toxicol Appl Pharmacol; 2009 Dec; 241(2):246-52. PubMed ID: 19716840
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Identification of the expression profile of apoptotic esophageal cancer cells by adenoviral-fragile histidine triad treatment.
    Mimori K; Ishii H; Inoue H; Barnard GF; Mori M
    J Gastroenterol Hepatol; 2008 Dec; 23 Suppl 2():S205-9. PubMed ID: 19120899
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Aberration of the enzymatic activity of Fhit tumor suppressor protein enhances cancer cell death upon photodynamic therapy similarly to that driven by wild-type Fhit.
    Ferens B; Kawiak A; Banecki B; Bielawski KP; Zawacka-Pankau J
    Cancer Lett; 2009 Jul; 280(1):101-9. PubMed ID: 19286306
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Down-regulation of FHIT inhibits apoptosis of colorectal cancer: mechanism and clinical implication.
    Cao J; Li W; Xie J; Du H; Tang W; Wang H; Chen X; Xiao W; Li Y
    Surg Oncol; 2006 Dec; 15(4):223-33. PubMed ID: 17382535
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The mechanism of action of the fragile histidine triad, Fhit: isolation of a covalent adenylyl enzyme and chemical rescue of H96G-Fhit.
    Huang K; Arabshahi A; Wei Y; Frey PA
    Biochemistry; 2004 Jun; 43(23):7637-42. PubMed ID: 15182206
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Diadenosines as FHIT-ness instructors.
    Campiglio M; Bianchi F; Andriani F; Sozzi G; Tagliabue E; Ménard S; Roz L
    J Cell Physiol; 2006 Aug; 208(2):274-81. PubMed ID: 16547961
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Expression in Escherichia coli and simple purification of human Fhit protein.
    Pawelczyk T; Kowara R; Golebiowski F; Matecki A
    Protein Expr Purif; 2000 Apr; 18(3):320-6. PubMed ID: 10733886
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Synthesis and biological evaluation of new symmetrical derivatives as cytotoxic agents and apoptosis inducers.
    Sanmartín C; Echeverría M; Mendívil B; Cordeu L; Cubedo E; García-Foncillas J; Font M; Palop JA
    Bioorg Med Chem; 2005 Mar; 13(6):2031-44. PubMed ID: 15727857
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Tumor suppressor Fhit protein interacts with protoporphyrin IX in vitro and enhances the response of HeLa cells to photodynamic therapy.
    Zawacka-Pankau J; Kowalska A; Issaeva N; Burcza A; Kwiek P; Bednarz N; Pramanik A; Banecki B; Podhajska AJ
    J Photochem Photobiol B; 2007 Jan; 86(1):35-42. PubMed ID: 16990010
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Ternary dinuclear copper(II) complexes of a hydroxybenzamide ligand with diimine coligands: the 5,6-dmp ligand enhances DNA binding and cleavage and induces apoptosis.
    Ramakrishnan S; Shakthipriya D; Suresh E; Periasamy VS; Akbarsha MA; Palaniandavar M
    Inorg Chem; 2011 Jul; 50(14):6458-71. PubMed ID: 21671566
    [TBL] [Abstract][Full Text] [Related]  

  • 35. New interactions between tumor suppressor Fhit protein and a nonhydrolyzable analog of its A
    Krakowiak A; Kocoń-Rębowska B; Dolot R; Piotrzkowska D
    FEBS Lett; 2017 Feb; 591(3):548-559. PubMed ID: 28094435
    [TBL] [Abstract][Full Text] [Related]  

  • 36. In vitro inhibition of the enzymatic activity of tumor suppressor FHIT gene product by carcinogenic transition metals.
    Kowara R; Karaczyn AA; Fivash MJ; Kasprzak KS
    Chem Res Toxicol; 2002 Mar; 15(3):319-25. PubMed ID: 11896678
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Loss of fragile histidine triad gene expression in advanced lung cancer is consequent to allelic loss at 3p14 locus and promoter methylation.
    Wali A; Srinivasan R; Shabnam MS; Majumdar S; Joshi K; Behera D
    Mol Cancer Res; 2006 Feb; 4(2):93-9. PubMed ID: 16513840
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Two hydrolase resistant analogues of diadenosine 5',5"'-P1,P3-triphosphate for studies with Fhit, the human fragile histidine triad protein.
    Blackburn GM; Liu X; Rösler A; Brenner C
    Nucleosides Nucleotides; 1998; 17(1-3):301-8. PubMed ID: 9708352
    [TBL] [Abstract][Full Text] [Related]  

  • 39. FHIT protein enhances paclitaxel-induced apoptosis in lung cancer cells.
    Kim CH; Yoo JS; Lee CT; Kim YW; Han SK; Shim YS; Yoo CG
    Int J Cancer; 2006 Apr; 118(7):1692-8. PubMed ID: 16231322
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Expression of FRA16D/WWOX and FRA3B/FHIT genes in hematopoietic malignancies.
    Ishii H; Vecchione A; Furukawa Y; Sutheesophon K; Han SY; Druck T; Kuroki T; Trapasso F; Nishimura M; Saito Y; Ozawa K; Croce CM; Huebner K; Furukawa Y
    Mol Cancer Res; 2003 Nov; 1(13):940-7. PubMed ID: 14638866
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.